Minna Padi Investama Sekuritas Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Minna Padi Investama Sekuritas Tbk. trades at Rp72 (market cap 963.38B, 101.89M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Minna Padi Investama Sekuritas Tbk. is far larger — about 9.2× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| PADI | SCPI | |
|---|---|---|
Market Cap | 963.38B | 104.4B |
Volume | 101.89M | — |
Lot | 1.02M | — |
Turnover | 7.25B | — |
Average Price | 71.12 | — |
Value | 7.25B | — |
Indicative Equilibrium Price | 72 | — |
Indicative Equilibrium Volume | 49.96K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Minna Padi Investama Tbk (formerly PT Batavia Artatama Securindo) was established by No Deed. 79 dated May 28, 1998 of Notary Drs. Atrino Leswara, SH. This Deed has been approved by the Ministry of Justice of the Republic of Indonesia in his Decree No. C2-8234.HT 01.01.Th.98 dated July 3, 1998 and was published in the Official Gazette Republic of Indonesia No.. 86 dated October 27, 2006, Supplement. 11489.
Read more on PADI →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →